TRIPELENNAMINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for tripelennamine hydrochloride and what is the scope of patent protection?
Tripelennamine hydrochloride
is the generic ingredient in three branded drugs marketed by Novartis, Anabolic, Barr, Heather, Impax Labs, Lannett, Nylos, Parke Davis, and Watson Labs, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for tripelennamine hydrochloride.
Summary for TRIPELENNAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 9 |
| NDAs: | 14 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Patent Applications: | 1,309 |
| DailyMed Link: | TRIPELENNAMINE HYDROCHLORIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRIPELENNAMINE HYDROCHLORIDE
US Patents and Regulatory Information for TRIPELENNAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nylos | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 085412-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lannett | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 083557-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Barr | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 080744-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Impax Labs | TRIPELENNAMINE HYDROCHLORIDE | tripelennamine hydrochloride | TABLET;ORAL | 080785-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | PBZ-SR | tripelennamine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 010533-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novartis | PBZ | tripelennamine hydrochloride | TABLET;ORAL | 083149-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
